• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在下肢血管腔内血管重建术中联合使用评分法和西罗莫司药物涂层球囊治疗慢性肢体威胁性缺血:病例系列

Combination therapy using scoring and sirolimus drug-coated balloons during lower limb endovascular revascularization for chronic limb threatening ischaemia: A case series.

作者信息

Bong Tiffany Sh, Yap Charyl Jq, Soon Shereen Xy, Tang Tjun Y

机构信息

Department of Vascular Surgery, Singapore General Hospital, Singapore.

Duke-NUS Graduate Medical School, Singapore.

出版信息

SAGE Open Med Case Rep. 2022 Mar 17;10:2050313X221085859. doi: 10.1177/2050313X221085859. eCollection 2022.

DOI:10.1177/2050313X221085859
PMID:35320985
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8935410/
Abstract

The aim of this case series was to document our early experience using combination therapy with ™ percutaneous transluminal angioplasty balloon (BD Interventional, New Jersey, US) and ™ (M.A. MedAlliance SA, Nyon, Switzerland) sirolimus-coated balloon catheter for anti-restenotic drug elution, in the setting of multifocal high-grade stenosis for chronic limb threatening ischaemia. Our anecdotal experience was that preparing the lesion with scoring balloon and then using sirolimus drug-eluting balloon may have synergistic effect when used in tandem, especially in the setting of calcified arterial lesions, where the scoring wires may achieve deeper clefts within the atheromatous plaque to allow better drug absorption into the arterial wall. We report two cases with high-grade multifocal stenosis affecting the superficial femoral and anterior tibial arteries, respectively. Combination therapy using the scoring balloon to first prepare the lesion followed by sirolimus elution achieved technical and procedural success in both cases and a 100% 30-day primary patency. There were no complications related to flow-limiting dissections, vessel perforation or acute recoil. However, whether this combination therapy leads to better primary vessel patency with longer freedom from target lesion revascularization in the medium term remains to be determined.

摘要

本病例系列的目的是记录我们在慢性肢体威胁性缺血的多灶性重度狭窄情况下,使用经皮腔内血管成形术球囊(美国新泽西州BD介入公司)和西罗莫司涂层球囊导管(瑞士尼永M.A. MedAlliance SA公司)联合治疗进行抗再狭窄药物洗脱的早期经验。我们的经验是,先用刻痕球囊预处理病变,然后使用西罗莫司药物洗脱球囊,串联使用时可能具有协同作用,特别是在钙化动脉病变的情况下,刻痕导丝可在动脉粥样硬化斑块内形成更深的裂隙,以便药物更好地吸收进入动脉壁。我们报告了两例分别累及股浅动脉和胫前动脉的多灶性重度狭窄病例。在这两例病例中,先用刻痕球囊预处理病变,然后进行西罗莫司洗脱的联合治疗均取得了技术和操作上的成功,30天的初次通畅率为100%。没有与血流限制性夹层、血管穿孔或急性回缩相关的并发症。然而,这种联合治疗是否能在中期带来更好的原发血管通畅率以及更长时间的免于靶病变血运重建,仍有待确定。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeb8/8935410/7331dc827bc2/10.1177_2050313X221085859-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeb8/8935410/e5c183aa5348/10.1177_2050313X221085859-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeb8/8935410/7331dc827bc2/10.1177_2050313X221085859-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeb8/8935410/e5c183aa5348/10.1177_2050313X221085859-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeb8/8935410/7331dc827bc2/10.1177_2050313X221085859-fig2.jpg

相似文献

1
Combination therapy using scoring and sirolimus drug-coated balloons during lower limb endovascular revascularization for chronic limb threatening ischaemia: A case series.在下肢血管腔内血管重建术中联合使用评分法和西罗莫司药物涂层球囊治疗慢性肢体威胁性缺血:病例系列
SAGE Open Med Case Rep. 2022 Mar 17;10:2050313X221085859. doi: 10.1177/2050313X221085859. eCollection 2022.
2
Intervention with selution SLR™ Agent Balloon for Endovascular Latent Limus therapy for failing AV Fistulas (ISABELLA) Trial: Protocol for a pilot clinical study and pre-clinical results.SLR™ 剂球囊血管内潜伏雷帕霉素治疗失败动静脉瘘(ISABELLA)试验的干预:一项先导性临床研究和临床前结果的方案。
J Vasc Access. 2023 Mar;24(2):289-299. doi: 10.1177/11297298211020867. Epub 2021 Jul 3.
3
The Utility of Sirolimus Eluting Balloons in the Setting of Chronic Limb Threatening Ischaemia in Asian Patients from Singapore - 12 Months Results of the PRISTINE Registry.新加坡亚洲患者慢性肢体威胁性缺血时西罗莫司洗脱球囊的应用 - PRISTINE 注册研究 12 个月结果。
Cardiovasc Intervent Radiol. 2024 Jul;47(7):863-874. doi: 10.1007/s00270-024-03756-3. Epub 2024 Jun 19.
4
World's First Experience Treating TASC II C and D Tibial Occlusive Disease Using the Selution SLR Sirolimus-Eluting Balloon: Six-Month Results From the PRESTIGE Study.世界首例采用 Selution SLR 西罗莫司洗脱球囊治疗 TASC II C 和 D 型胫骨闭塞性病变的经验:来自 PRESTIGE 研究的 6 个月结果。
J Endovasc Ther. 2021 Aug;28(4):555-566. doi: 10.1177/15266028211007457. Epub 2021 Apr 12.
5
Six-Month Outcomes From the First-in-Human, Single-Arm SELUTION Sustained-Limus-Release Drug-Eluting Balloon Trial in Femoropopliteal Lesions.首例人体单臂SELUTION持续释放雷帕霉素药物洗脱球囊治疗股腘动脉病变试验的六个月结果
J Endovasc Ther. 2020 Oct;27(5):683-690. doi: 10.1177/1526602820941811. Epub 2020 Jul 15.
6
Slow-flow phenomena following lower limb paclitaxel- and sirolimus-coated balloon angioplasty in the setting of chronic limb threatening ischaemia-a case series.慢性肢体威胁性缺血情况下下肢紫杉醇和西罗莫司涂层球囊血管成形术后的慢血流现象——病例系列
Quant Imaging Med Surg. 2022 Mar;12(3):2058-2065. doi: 10.21037/qims-21-633.
7
Long-term outcome upon treatment of calcified lesions of the lower limb using scoring angioplasty balloon (AngioSculpt™).应用评分球囊血管成形术(AngioSculpt™)治疗下肢钙化病变的长期疗效。
Clin Res Cardiol. 2020 Sep;109(9):1177-1185. doi: 10.1007/s00392-020-01610-3. Epub 2020 Feb 8.
8
Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.下肢外周动脉疾病的支架置入术:一项基于证据的分析。
Ont Health Technol Assess Ser. 2010;10(18):1-88. Epub 2010 Sep 1.
9
The SELUTION SLR™ drug-eluting balloon system for the treatment of symptomatic femoropopliteal lesions.SELUTION SLR™ 药物洗脱球囊系统,用于治疗有症状的股腘动脉病变。
Future Cardiol. 2021 Mar;17(2):257-267. doi: 10.2217/fca-2020-0085. Epub 2020 Aug 20.
10
Effectiveness of combined superficial femoral artery endovascular therapy with popliteal-to-distal bypass: A paradigm shift in surgical open bypass for chronic limb-threatening ischemia.股浅动脉腔内治疗联合腘动脉至远端旁路移植术的有效性:慢性肢体威胁性缺血手术开放旁路移植术的范式转变。
Vascular. 2021 Dec;29(6):905-912. doi: 10.1177/1708538120981224. Epub 2020 Dec 21.

引用本文的文献

1
Treatment of Peripheral Artery Disease Using Injectable Biomaterials and Drug-Coated Balloons: Safety and Efficacy Perspective.使用可注射生物材料和药物涂层球囊治疗外周动脉疾病:安全性和有效性视角
Pharmaceutics. 2023 Jun 25;15(7):1813. doi: 10.3390/pharmaceutics15071813.
2
Propensity score-matched analysis of six-month outcomes of paclitaxel-coated balloons combined with UltraScore balloons versus conventional scoring balloons for femoropopliteal lesions.紫杉醇涂层球囊联合 UltraScore 球囊与传统评分球囊治疗股腘动脉病变 6 个月结局的倾向评分匹配分析。
Diagn Interv Radiol. 2023 May 31;29(3):535-541. doi: 10.4274/dir.2023.232114. Epub 2023 Apr 17.

本文引用的文献

1
Prospective Study of Serration Angioplasty in the Infrapopliteal Arteries Using the Serranator Device: PRELUDE BTK Study.采用 Serranator 装置行锯齿样扩张成形术治疗小腿动脉病变的前瞻性研究:PRELUDE BTK 研究。
J Endovasc Ther. 2022 Aug;29(4):586-593. doi: 10.1177/15266028211059917. Epub 2021 Nov 20.
2
Editor's Choice - Risk of Major Amputation Following Application of Paclitaxel Coated Balloons in the Lower Limb Arteries: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.编辑精选 - 紫杉醇涂层球囊在下肢动脉中的应用后发生主要截肢的风险:随机对照试验的系统评价和荟萃分析。
Eur J Vasc Endovasc Surg. 2022 Jan;63(1):60-71. doi: 10.1016/j.ejvs.2021.05.027. Epub 2021 Jul 27.
3
Randomized Controlled Trial Comparing Drug-coated Balloon Angioplasty versus Conventional Balloon Angioplasty for Treating Below-the-Knee Arteries in Critical Limb Ischemia: The SINGA-PACLI Trial.
随机对照试验比较药物涂层球囊血管成形术与传统球囊血管成形术治疗下肢严重缺血的膝下动脉:SINGA-PACLI 试验。
Radiology. 2021 Sep;300(3):715-724. doi: 10.1148/radiol.2021204294. Epub 2021 Jul 6.
4
World's First Experience Treating TASC II C and D Tibial Occlusive Disease Using the Selution SLR Sirolimus-Eluting Balloon: Six-Month Results From the PRESTIGE Study.世界首例采用 Selution SLR 西罗莫司洗脱球囊治疗 TASC II C 和 D 型胫骨闭塞性病变的经验:来自 PRESTIGE 研究的 6 个月结果。
J Endovasc Ther. 2021 Aug;28(4):555-566. doi: 10.1177/15266028211007457. Epub 2021 Apr 12.
5
WIfI Classification Versus Angiosome Concept: A Change in the Infrapopliteal Angioplasties Paradigm.WIfI 分级与血管单元概念:比目鱼肌内下血管成形术治疗模式的改变。
Ann Vasc Surg. 2021 Feb;71:338-345. doi: 10.1016/j.avsg.2020.07.049. Epub 2020 Aug 12.
6
High-pressure, non compliant balloon angioplasty for long and calcified infrapopliteal and inframalleolar lesions is feasible.高压、非顺应性球囊血管成形术治疗长段、钙化的膝下和踝下病变是可行的。
Int Angiol. 2020 Oct;39(5):390-397. doi: 10.23736/S0392-9590.20.04375-8. Epub 2020 May 13.
7
Usefulness of the "Non-Slip Element" Percutaneous Transluminal Angioplasty Balloon in the Treatment of Femoropopliteal Arterial Lesions.“防滑元件”经皮腔内血管成形术球囊在股腘动脉病变治疗中的应用。
J Endovasc Ther. 2020 Feb;27(1):102-108. doi: 10.1177/1526602819887954. Epub 2019 Nov 14.
8
Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia.全球血管指南:慢性肢体威胁性缺血的管理。
Eur J Vasc Endovasc Surg. 2019 Jul;58(1S):S1-S109.e33. doi: 10.1016/j.ejvs.2019.05.006. Epub 2019 Jun 8.
9
Impact of calcification and infrapopliteal outflow on the outcome of endovascular treatment of femoropopliteal occlusive disease.钙化和腘动脉以下流出道对股腘动脉闭塞性疾病血管内治疗结果的影响。
JRSM Cardiovasc Dis. 2019 Feb 10;8:2048004019828941. doi: 10.1177/2048004019828941. eCollection 2019 Jan-Dec.
10
Treatment of femoropopliteal lesions with the AngioSculpt scoring balloon - results from the Heidelberg PANTHER registry.使用AngioSculpt评分球囊治疗股腘病变——海德堡PANTHER注册研究结果
Vasa. 2018 Jan;47(1):49-55. doi: 10.1024/0301-1526/a000671. Epub 2017 Nov 8.